REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.50
Bid: 38.00
Ask: 39.00
Change: 2.00 (5.48%)
Spread: 1.00 (2.632%)
Open: 37.00
High: 40.50
Low: 36.75
Prev. Close: 36.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Northamber loss widens; Ethernity contract boost

Thu, 28th Mar 2024 13:44

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Northamber PLC - London-based distributor of audio-visual and information technology equipment - Revenue in the six months to December 31 falls to GBP29.2 million from GBP33.6 million while pretax loss widens to GBP413,000 from GBP250,000. Notes broader macro-economic factors and market sentiment impacted the industry. Explains softer demand resulted in slower stock turns, leading to an increase in stock at period end of GBP10.3 million compared to GBP9.6 million. Proposes unchanged interim dividend of 0.3p. Remains cautious short term as the UK market continues to be challenging but notes industry analysts expect a recovery through 2024 in demand levels as business confidence hopefully returns.

----------

Ethernity Networks Ltd - Israel-based supplier of data processing semiconductor technology for networking appliances - Announces business update. Highlights positive engagement with a number of potential new customers, including two OEM vendors which, following an extensive evaluation of Ethernity's Universal Edge Platform have indicated an interest to adopt and launch the product to their customer base. Talks continue with these two vendors on potential contracts that could lead to significant business for Ethernity. Estimates the contracts could contribute between USD2.2 million and USD3 million to revenue in 2024, plus "significantly higher revenues in 2025 and beyond".

----------

Rurelec PLC - gas producer focused on operations in Latin America - Reports pretax profit in the six months to December 31 of GBP559,000, swinging from pretax loss of GBP2.9 million. Earnings per share total 0.09 pence compared to LPS of 0.51p. Administration expenses decline to GBP0.31 million from GBP0.48 million. Explains the board's strategy is now to seek a reverse takeover "through which to generate value for our shareholders, and to give the company access to further resource thereby allowing more time to achieve a sale of the two Siemens 701 turbines." Adds: "While we continue to hold discussions with credible potential purchasers of the turbines, these initiatives are at an early stage following the withdrawal of counterparties to our earlier discussions for reasons unconnected with Rurelec. The timing of any potential sale of the turbines remains highly uncertain owing to the limited demand and infrequent occurrence of projects into which the turbines could be injected."

----------

Sareum Holdings PLC - Reports pretax loss in the six months to December 31 widens to GBP3.3 million from GBP1.7 million. No revenue was disclosed as per the year prior. Operating expenses rise to GBP2.5 million from GBP1.7 million. Basic and diluted loss per share totals 3.6 pence compared to 2.1p. Further, raises GBP1.5 million via placing, subscription and retail offer at 10p per share. Intends to use proceeds to complete Phase 1a clinical studies on its SDC-1801 TYK2/JAK1 inhibitor and, together with the receipt of an anticipated R&D tax credit of GBP0.7 million for general working capital purposes.

----------

Team PLC - wealth, asset management and complementary financial services group - Plans to raise GBP1.1 million via GBP700,000 placing and GBP400,000 subscription at 20 pence per share. Explains funds will be used for the financing of acquisitions and deferred consideration, as well as providing cash for working capital and general corporate purposes. Notes fundraise is supported by existing and new shareholders. Further, intends to raise GBP750,000 via retail offer.

----------

First Tin PLC - London-based tin development company focused on advanced, low-capital expenditure projects in Germany and Australia - Reports pretax loss in 2023 narrows to GBP2.3 million from GBP3.2 million the year prior. Diluted loss per share totals 0.85 pence compared to 1.40p. Says 2024 is shaping up to be "another busy year" with the definitive feasibility study at the Taronga asset soon to be completed and the finalisation of the mineral resource estimate at the Tellerhauser asset in the third quarter. "Our outlook for the tin market remains bullish, and we are already seeing strong signs of tin price recovery. The demand for tin remains ever-present as tin becomes increasingly recognised as crucial to the global energy transition and digital revolution," company states.

----------

Home REIT PLC - London-based real estate company, which focuses on investing in accommodation for homeless people - Sells 63 properties for GBP6.1 million, around 1.8% of the company's portfolio by value. Notes gross proceeds from the sales are GBP0.5 million, below the draft August 2023 values. Explains the majority of the properties sold are below portfolio average lot size which may cause a greater percentage variation when comparing sale price to the August draft valuation. Since August 2023, the company has completed on the sale of 451 properties and exchanged on a further 257 properties. Sale proceeds will be used to reduce borrowings and provide working capital.

----------

React Group PLC - Birmingham, England-based cleaning, hygiene and decontamination firm - Issues trading statement ahead of Thursday's annual general meeting. Reports that revenue for the first five months of the current financial year ending September is ahead of the same period in last year. Says: "Each division has performed well and the group continues to benefit from cross selling opportunities which not only enhance our offering but also contribute to the organic growth. It is particularly pleasing to deliver revenue growth in a challenging market environment where our customers are always striving for the best in class service that we offer."

----------

Westminster Group PLC - London-based provider of security services, for sensitive places such as ports, airports and commercial buildings - Revenue in the six months to December 31 falls to GBP2.9 million from GBP3.5 million the year before, while pretax loss widens to GBP1.9 million from GBP287,000. Loss per share totals 0.58 pence compared to 0.09p. Chief Executive Peter Fowler says: "We continue to battle against probably one of the worst world economic and political backgrounds in recent times." Explains revenue fell largely due to the economic climate delaying some capital-intensive orders. Fowler adds: "We started 2024 with an order book of GBP1.1 million and recurring revenues of GBP3.7 million which provide a healthy start for the year. With DRC expected to come on stream and other potential projects in the pipeline we believe the months and year ahead will be transformative for the group."

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
13 Sep 2022 08:13

CORRECT: Sareum notes US FDA approval of Bristol-Myers's Sotyktu

(Correcting that Bristol-Myers gained US FDA approval, not Sareum.)

Read more
12 Sep 2022 12:27

Sareum receives US US Food & Drug Administration approval for Sotyktu

(Alliance News) - Sareum Holdings PLC on Monday said the US Food & Drug Administration has approved Sotyktu, a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor.

Read more
4 Jul 2022 11:23

IN BRIEF: Sareum notes updated payment terms after GSK buy of SRA737

Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - Notes that GSK PLC has completed its acquisition of Sierra Oncology Inc, the licence holder of SRA737, for USD1.9 billion. SRA737 was discovered and initially developed by scientists at the Institute of Cancer Research in collaboration with Sareum.

Read more
10 Jun 2022 11:19

Midatech Chair Rolf Stahel retires; Stephen Parker named as successor

(Alliance News) - Midatech Pharma PLC on Friday said that Chair Rolf Stahel plans to leave the board on June 20, and it named Stephen Parker as his successor.

Read more
13 Apr 2022 21:59

TRADING UPDATES: Sureserve gets new CFO; Sareum notes GSK buys Sierra

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Apr 2022 19:46

TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
11 Apr 2022 20:51

TRADING UPDATES: Pod Point wins BMW deal; Lamprell seals contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
16 Mar 2022 14:21

Sareum progresses Covid-19 and autoimmune treatment candidate

(Sharecast News) - Specialist drug developer Sareum Holdings updated the market on the development of its 'SDC-1801' - a potential Covid-19 and autoimmune disease treatment - towards first-in-human trials on Wednesday.

Read more
21 Feb 2022 18:13

TRADING UPDATES: Bank of Cyprus swings profit; Sareum loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
21 Feb 2022 15:55

UK shareholder meetings calendar - next 7 days

Tuesday 22 February 
Aberdeen Diversified Income & Growth Trust PLCAGM
Image Scan Holdings PLCAGM
Montanaro European Smaller Cos Trust PLCGM share issue
Wednesday 23 February 
Blencowe Resources PLCAGM
Gooch & Housego PLCAGM
Income & Growth VCT PLCGM re share subscription
Mobeus Income & Growth 2 VCT PLCGM re share subscription
Mobeus Income & Growth 4 VCT PLCGM re share subscription
Mobeus Income & Growth VCT PLCGM re share subscription
RWS Holdings PLCAGM
Tharisa PLCAGM
Titon Holdings PLCAGM
Thursday 24 February 
Bankers Investment Trust PLCAGM
IntegraFin Holdings PLCAGM
Victorian Plumbing Group PLCAGM
Friday 25 February 
Caledonian Trust PLCAGM
GRIT Investment Trust PLCAGM
Henderson Diversified Income Trust PLCGM re investment policy
On the Beach Group PLCAGM
Ruffer Investment Co LtdEGM re authority to issue shares
Monday 28 February 
Alternative Liquidity Fund LtdEGM
Ramsdens Holdings PLCAGM
Sareum Holdings PLCEGM re share consolidation
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
4 Feb 2022 14:37

IN BRIEF: Drug maker Sareum plans 50-into-1 share consolidation

IN BRIEF: Drug maker Sareum plans 50-into-1 share consolidation

Read more
17 Dec 2021 19:28

IN BRIEF: Sareum raises GBP1.6 million to advance inhibitor programmes

IN BRIEF: Sareum raises GBP1.6 million to advance inhibitor programmes

Read more
9 Dec 2021 14:43

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
23 Nov 2021 16:21

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares

Read more
25 Oct 2021 08:48

Sareum full-year loss widens on research & development costs

Sareum full-year loss widens on research & development costs

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.